Home › Juvenile Arthritis › Indiana
Juvenile Arthritis clinical trials in Indiana
3 studies for Juvenile Arthritis are looking for participants at sites in Indiana.
Cities in Indiana
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Riley Hospital for Children, Indianapolis
RecruitingPhase 3
Ages 3 and older · All sexes · Updated Nov 3, 2026 · NCT06663332Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
- Indiana University School of Medicine, Indianapolis
RecruitingObservational study
Up to age 21 · All sexes · Updated Oct 21, 2026 · NCT02418442A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
- Indiana University Health Riley Hospital for Children /ID# 259067, Indianapolis
RecruitingPhase 3
Ages 5 to 17 · All sexes · Updated Sep 1, 2026 · NCT06100744From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.